Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection
Efforts to develop a treatment for bupivacaine cardiotoxicity led to the discovery that Intralipid, a popular brand of intravenous lipid emulsion, could be used not only as an effective treatment for anesthetic-induced cardiac arrest, but also as a means of reversing many other toxicities. Contradic...
Main Authors: | Negar Motayagheni, Sheshanna Phan, Ala Nozari, Anthony Atala |
---|---|
Format: | Article |
Language: | English |
Published: |
Canadian Society for Pharmaceutical Sciences
2018-01-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/29471 |
Similar Items
-
Magnesium sulphate reversal of established bupivacaine electrophysiological cardiotoxicity
by: Reed, Anthony Raddon
Published: (2018) -
A review of local anesthetic cardiotoxicity and treatment with lipid emulsion
by: Emma Bourne, et al.
Published: (2010-02-01) -
Insulin effect on bupivacaine-induced cardiotoxicity in rabbits
by: Yun Suk Choi, et al.
Published: (2011-12-01) -
Chewing the fat: A case report on intravenous lipid emulsion to reverse cardiotoxicity from intentional amitriptyline overdose.
by: J. Hellig, et al.
Published: (2012-12-01) -
Lipid Emulsion Inhibits the Late Apoptosis/Cardiotoxicity Induced by Doxorubicin in Rat Cardiomyoblasts
by: Raghavendra Baregundi Subbarao, et al.
Published: (2018-09-01)